{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-9707", "postId": 9707, "name": "Endava plc", "description": "Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Endava To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Endava between September 4, 2025 and September 21, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Endava plc (\u201cEndava\u201d or the \u201cCompany\u201d) (NASDAQ: DAVA) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that that the accounting treatment for certain customer and supplier agreements and related matters required additional review; (2) that, as a result of the foregoing, the Company would delay the release of its fourth quarter and full year 2026 financial results; (3) that there was reason to doubt the effectiveness of the Company\u2019s internal controls and procedures; and (4) that, as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Lead Plaintiff Deadline: November 30, 2026 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.", "identifier": "DAVA", "legal": { "court": "United States District Court for the Southern District of New York", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "09/04/2025", "end": "09/21/2026" }, "leadPlaintiffDeadline": "11/30/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/endava-plc/", "canonicalUrl": "https://faruqilaw.com/case/endava-plc/", "datePublished": "2026-09-29T21:04:39+00:00", "dateModified": "2026-09-29T21:12:05+00:00", "associatedOrganization": { "@id": "case-9707-org" }, "legalService": { "@id": "case-9707-legalservice" }, "hasPart": [ { "@id": "case-9707-faq" }, { "@id": "case-9707-press-list" } ], "legalRepresentation": [ { "@id": "case-9707-attorney-516" }, { "@id": "case-9707-attorney-506" } ] }, { "@type": "Organization", "@id": "case-9707-org", "name": "Endava plc", "identifier": "DAVA", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.endava.com/" }, { "@type": "LegalService", "@id": "case-9707-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-9707-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-9707-legalservice" } }, { "@type": "Person", "@id": "case-9707-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-9707-legalservice" } }, { "@type": "FAQPage", "@id": "case-9707-faq", "mainEntity": [ { "@type": "Question", "name": "Why is Endava plc facing a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit concerns Endava\u2019s accounting treatment of certain customer and supplier agreements and related matters, which became the subject of an investigation by independent outside counsel." } }, { "@type": "Question", "name": "What are the main allegations in the Endava securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The action concerns whether Endava made materially false or misleading statements or omitted material information regarding its accounting practices and related financial disclosures." } }, { "@type": "Question", "name": "Why was Endava CFO Mark Thurston placed on administrative leave?", "acceptedAnswer": { "@type": "Answer", "text": "Endava announced that CFO Mark Thurston was placed on administrative leave upon the recommendation of the Board\u2019s Audit Committee, pending completion of an ongoing investigation." } }, { "@type": "Question", "name": "What accounting issues are involved in the Endava securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Endava disclosed that its outside auditors raised concerns about the Company\u2019s accounting treatment of certain customer and supplier agreements and related matters." } }, { "@type": "Question", "name": "Who is investigating Endava\u2019s accounting practices?", "acceptedAnswer": { "@type": "Answer", "text": "Endava disclosed that independent outside counsel is conducting an investigation for the Audit Committee after the Company\u2019s outside auditors raised accounting concerns." } }, { "@type": "Question", "name": "Why did Endava\u2019s outside auditors raise concerns?", "acceptedAnswer": { "@type": "Answer", "text": "According to Endava, its outside auditors raised concerns regarding the Company\u2019s accounting treatment of certain customer and supplier agreements and related matters." } }, { "@type": "Question", "name": "What happened to Endava stock after the accounting investigation was disclosed?", "acceptedAnswer": { "@type": "Answer", "text": "Endava ADS fell $0.68, or 24.37%, to close at $2.11 on September 22, 2026, following disclosure of the investigation and the CFO\u2019s administrative leave." } }, { "@type": "Question", "name": "What are Endava American Depositary Shares, or ADS?", "acceptedAnswer": { "@type": "Answer", "text": "American Depositary Shares allow U.S. investors to invest in shares of foreign companies through U.S. markets. Endava\u2019s ADS trade on Nasdaq under the ticker DAVA." } }, { "@type": "Question", "name": "What period is covered by the Endava securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The alleged Class Period covers investors who purchased or acquired Endava securities between September 4, 2025 and September 21, 2026." } }, { "@type": "Question", "name": "Who may be eligible to participate in the Endava securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased or acquired Endava plc (NASDAQ: DAVA) securities between September 4, 2025 and September 21, 2026 may be eligible if they suffered losses." } }, { "@type": "Question", "name": "What is the lead plaintiff deadline in the Endava securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "Eligible Endava investors seeking appointment as lead plaintiff must file a motion with the court by November 30, 2026." } }, { "@type": "Question", "name": "What is a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "A securities class action allows investors to collectively pursue claims involving alleged material misstatements, misleading disclosures, or omissions concerning publicly traded securities." } }, { "@type": "Question", "name": "What does the class period mean in a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "The class period identifies the timeframe during which the alleged misconduct occurred and qualifying investors purchased or otherwise acquired the securities at issue." } }, { "@type": "Question", "name": "What is a lead plaintiff in a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "A lead plaintiff is an investor appointed by the court to represent the proposed class and help oversee the litigation on behalf of class members." } }, { "@type": "Question", "name": "Do Endava investors need to become lead plaintiff to participate in a potential recovery?", "acceptedAnswer": { "@type": "Answer", "text": "No. Eligible Endava investors generally do not need to serve as lead plaintiff to participate in a potential settlement or other class-wide recovery." } } ] }, { "@type": "NewsArticle", "@id": "case-9707-press-1", "headline": "Endava shares plunge 25% amid management shakeup and accounting probe.", "url": "https://pluang.com/en/news-feed/endava-plc-dava-diperiksa-akibat-cfo-diberhentikan-dan-penurunan-saham-25-persen", "datePublished": "2026-09-25" }, { "@type": "NewsArticle", "@id": "case-9707-press-2", "headline": "Endava stock falls as CFO investigation shakes confidence", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/endava-stock-falls-as-cfo-investigation-shakes-confidence/70161799", "datePublished": "2026-09-23" }, { "@type": "NewsArticle", "@id": "case-9707-press-3", "headline": "Endava stock rating cut to underperform by William Blair on CFO exit", "url": "https://www.investing.com/news/analyst-ratings/endava-stock-rating-cut-to-underperform-by-william-blair-on-cfo-exit-93CH-4910377", "datePublished": "2026-09-22" }, { "@type": "NewsArticle", "@id": "case-9707-press-4", "headline": "William Blair Downgrades Endava to Underperform From Market Perform", "url": "https://finance.yahoo.com/markets/stocks/articles/william-blair-downgrades-endava-underperform-105115069.html", "datePublished": "2026-09-22" }, { "@type": "NewsArticle", "@id": "case-9707-press-5", "headline": "Endava stock falls as accounting investigation reshapes guidance", "url": "https://www.ad-hoc-news.de/boerse/news/nebenwerte/endava-stock-falls-as-accounting-investigation-reshapes-guidance/70151288#google_vignette", "datePublished": "2026-09-22" }, { "@type": "NewsArticle", "@id": "case-9707-press-6", "headline": "Endava stock tumbles 10% on CFO leave, accounting probe", "url": "https://www.investing.com/news/stock-market-news/endava-stock-tumbles-10-on-cfo-leave-accounting-probe-93CH-4909666", "datePublished": "2026-09-21" }, { "@type": "NewsArticle", "@id": "case-9707-press-7", "headline": "Endava Appoints Conor McShane as Interim Chief Financial Officer", "url": "https://finance.yahoo.com/markets/stocks/articles/endava-appoints-conor-mcshane-interim-210400710.html", "datePublished": "2026-09-21" }, { "@type": "ItemList", "@id": "case-9707-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-9707-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-9707-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-9707-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-9707-press-4" } }, { "@type": "ListItem", "position": 5, "item": { "@id": "case-9707-press-5" } }, { "@type": "ListItem", "position": 6, "item": { "@id": "case-9707-press-6" } }, { "@type": "ListItem", "position": 7, "item": { "@id": "case-9707-press-7" } } ] } ] }

Endava plc

Endava plc

Join Action
Case Details
Ticker DAVA
Class Period 09/04/2025 - 09/21/2026
Lead Plaintiff Deadline 11/30/2026
Days Left to Seek Lead Plaintiff
62

If you are a Endava investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Endava To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Endava between September 4, 2025 and September 21, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Endava plc (“Endava” or the “Company”) (NASDAQ: DAVA) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that that the accounting treatment for certain customer and supplier agreements and related matters required additional review; (2) that, as a result of the foregoing, the Company would delay the release of its fourth quarter and full year 2026 financial results; (3) that there was reason to doubt the effectiveness of the Company’s internal controls and procedures; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Lead Plaintiff Deadline: November 30, 2026

Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.

Join Action
Endava plc
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771